Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▴	Diluted EPS
BDPT	Bioadaptives, Inc. Manufacturing · Year ended 2025-12-31 · USD	$18.3K	-$1.56M	n/m	n/a	44.3%	-$0.15
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
RYTM	Rhythm Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$189.76M	-$196.54M	-103.6%	-141.3%	45.8%	-$3.11
AKBA	Akebia Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$236.20M	-$5.34M	-2.3%	-16.4%	47.5%	-$0.02
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
TNGX	Tango Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.38M	-$101.59M	-162.9%	-29.3%	48.3%	-$0.87
BGM	BGM Group Ltd. Manufacturing · Year ended 2025-09-30 · USD	$37.92M	-$19.94M	-52.6%	-5.1%	51.1%	-$0.18
LEXX	Lexaria Bioscience Corp. Manufacturing · Year ended 2025-08-31 · USD	$705.9K	-$11.90M	n/m	-398.1%	52.0%	-$0.66
NRIX	Nurix Therapeutics, Inc. Manufacturing · Year ended 2025-11-30 · USD	$83.98M	-$264.46M	-314.9%	-49.1%	54.0%	-$3.05
MIRM	Mirum Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$521.31M	-$23.36M	-4.5%	-7.4%	54.7%	-$0.47
RANI	Rani Therapeutics Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.63M	-$40.95M	n/m	-124.1%	58.9%	-$0.45
KNSA	Kiniksa Pharmaceuticals International, plc Manufacturing · Year ended 2025-12-31 · USD	$677.56M	$59.01M	8.7%	10.4%	60.1%	$0.75
LXRX	Lexicon Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$49.80M	-$50.34M	-101.1%	-46.8%	60.2%	-$0.14
LGND	Ligand Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$268.09M	$124.45M	46.4%	12.2%	60.4%	$6.13
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
SXTP	60 Degrees Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.01M	-$7.37M	-732.5%	-212.7%	65.5%	-$11.73
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
CPMD	Cannapharmarx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.36M	-$11.13M	-817.2%	n/a	66.1%	-$0.02
INSM	Insmed Inc Manufacturing · Year ended 2025-12-31 · USD	$606.42M	-$1.28B	-210.5%	-172.8%	66.7%	-$6.42
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
SLGL	Sol-Gel Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$19.39M	-$6.13M	-31.6%	-26.9%	68.0%	-$2.19
TXMD	TherapeuticsMD, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02M	-$569.0K	-18.8%	-2.1%	71.6%	-$0.05
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
ELTP	Elite Pharmaceuticals Inc Manufacturing · Year ended 2026-03-31 · USD	$148.87M	$44.87M	30.1%	45.4%	77.1%	$0.03
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22

Rows per page: 2550 100